Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
small cell lung cancer
Pharma
Jazz's almost-withdrawn lung cancer drug shows life
Jazz proposed two phase 3 trials to keep Zepzelca's accelerated approval a few years ago, and one of them has read out positively.
Angus Liu
Oct 15, 2024 10:15am
FDA noted 'large number' of missing AEs in Amgen's Imdelltra app
Aug 14, 2024 6:45am
ASCO: AZ's latest Tagrisso data receive standing ovation
Jun 3, 2024 7:37am
FDA approves Amgen's potential lung cancer blockbuster Imdelltra
May 17, 2024 12:12pm
AstraZeneca’s Imfinzi tackles another type of lung cancer
Apr 5, 2024 10:22am
Jazz's lung cancer drug keeps approval despite failed trial
Oct 26, 2022 2:54pm
